Planning and reporting of quality-of-life outcomes in cancer trials.

نویسندگان

  • S Schandelmaier
  • K Conen
  • E von Elm
  • J J You
  • A Blümle
  • Y Tomonaga
  • R Saccilotto
  • A Amstutz
  • T Bengough
  • J J Meerpohl
  • M Stegert
  • K K Olu
  • K A O Tikkinen
  • I Neumann
  • A Carrasco-Labra
  • M Faulhaber
  • S M Mulla
  • D Mertz
  • E A Akl
  • X Sun
  • D Bassler
  • J W Busse
  • I Ferreira-González
  • F Lamontagne
  • A Nordmann
  • V Gloy
  • H Raatz
  • L Moja
  • R Rosenthal
  • S Ebrahim
  • P O Vandvik
  • B C Johnston
  • M A Walter
  • B Burnand
  • M Schwenkglenks
  • L G Hemkens
  • H C Bucher
  • G H Guyatt
  • M Briel
  • B Kasenda
چکیده

BACKGROUND Information about the impact of cancer treatments on patients' quality of life (QoL) is of paramount importance to patients and treating oncologists. Cancer trials that do not specify QoL as an outcome or fail to report collected QoL data, omit crucial information for decision making. To estimate the magnitude of these problems, we investigated how frequently QoL outcomes were specified in protocols of cancer trials and subsequently reported. DESIGN Retrospective cohort study of RCT protocols approved by six research ethics committees in Switzerland, Germany, and Canada between 2000 and 2003. We compared protocols to corresponding publications, which were identified through literature searches and investigator surveys. RESULTS Of the 173 cancer trials, 90 (52%) specified QoL outcomes in their protocol, 2 (1%) as primary and 88 (51%) as secondary outcome. Of the 173 trials, 35 (20%) reported QoL outcomes in a corresponding publication (4 modified from the protocol), 18 (10%) were published but failed to report QoL outcomes in the primary or a secondary publication, and 37 (21%) were not published at all. Of the 83 (48%) trials that did not specify QoL outcomes in their protocol, none subsequently reported QoL outcomes. Failure to report pre-specified QoL outcomes was not associated with industry sponsorship (versus non-industry), sample size, and multicentre (versus single centre) status but possibly with trial discontinuation. CONCLUSIONS About half of cancer trials specified QoL outcomes in their protocols. However, only 20% reported any QoL data in associated publications. Highly relevant information for decision making is often unavailable to patients, oncologists, and health policymakers.

برای دانلود رایگان متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Depression, Anxiety, and Quality of Life in Breast Cancer Patients with Depression Receiving Citalopram and Supportive Group Psychotherapy: A Six-month Longitudinal Study

Background and purpose: Depression is a common psychiatric disorder in patients with breast cancer. This study was performed to follow-up breast cancer patients with depression receiving citalopram and group psychotherapy for six months. Materials and methods: This clinical trial was conducted in 40 breast cancer patients with depressive disorder. Among the patients, 20 received citalopram (20...

متن کامل

درماتولوژی مبتنی بر شواهد: گزارش درست مقایسه‌ی پیامدها در کارآزمایی‌های بالینی

According to evidence-based medicine, randomized controlled clinical trials are a group of research designs which provides the highest level of clinical evidence, particularly regarding therapeutic or preventive interventions. Considering the dramatic increase in the number of published clinical trials in medical journals, the readership need to have knowledge about the problems that may occur ...

متن کامل

Effect of a Discharge Planning Program on the Quality of Life in Women With Breast Cancer

Introduction: Women with Breast Cancer (BC) under chemotherapy are at risk of complications affecting their Quality of Life (QoL), which need specific discharge planning. Objective: This study aims to investigate the effect of a discharge planning program on the QoL of women with BC. Materials and Methods: This quasi-experimental study was conducted on 72 women with BC undergoing chemotherapy...

متن کامل

A Systematic Review of Clinical Practice Guidelines for Castration-Resistant Prostate Cancer

Cancer constitutes a huge burden on societies in countries with any level of economic development. Prostate cancer is the first most diagnosed cancer of men in developed countries and the forth one in developing countries in terms of incidence rate. It is also the third incident cancer of men in Iran along with a prevalence of about 10,000 cases. Castration-resistant prostate cancer (CRPC) is a...

متن کامل

A Systematic Review of Clinical Practice Guidelines for Castration-Resistant Prostate Cancer

Cancer constitutes a huge burden on societies in countries with any level of economic development. Prostate cancer is the first most diagnosed cancer of men in developed countries and the forth one in developing countries in terms of incidence rate. It is also the third incident cancer of men in Iran along with a prevalence of about 10,000 cases. Castration-resistant prostate cancer (CRPC) is a...

متن کامل

Exercise as a Treatment to Improve the Quality of Life in Patients with Cancer: A Review of the Literature

Objectives: Improvement in cancer care increases life expectancy of patients with cancer, most of whom have experienced prolonged episodes of fatigue during and after their treatment. This has been found to reduce the quality of life and increase morbidity and mortality of such patients. Therefore, additional interventions are beneficial to improve overall quality of life as well as longevity. ...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

عنوان ژورنال:
  • Annals of oncology : official journal of the European Society for Medical Oncology

دوره 27 1  شماره 

صفحات  -

تاریخ انتشار 2015